Arte SheetsLearn. Try. Understand.

Statistical & Clinical Analysis

UCSF-CAPRA Score: Pre-Treatment Prostate Cancer Risk Assessment

Add the five pre-assessed CAPRA components and interpret the resulting risk group in the context of the original research and UCSF guidance.

What the CAPRA score summarizes

The UCSF Cancer of the Prostate Risk Assessment (CAPRA) score uses information available at diagnosis: age, PSA, biopsy Gleason primary and secondary patterns, clinical T stage, and the percentage of positive biopsy cores. Each component receives a defined point value; the sum ranges from 0 to 10.

The 2005 original study derived a preoperative recurrence model in 1,439 men after radical prostatectomy. Later studies assessed it in other settings. Results depend on the study population, treatment and outcome definition, so a single score is not a guaranteed personal prediction.

Points to enter in this example

Enter PSA points 0–4, biopsy Gleason points 0, 1 or 3, clinical-stage points 0 or 1, positive-core points 0 or 1, and age points 0 or 1. These are pre-assessed component points, not raw laboratory measurements. The example checks all five values before adding them.

UCSF assigns 0 points when neither biopsy pattern is 4 or 5; 1 when a secondary pattern is 4 or 5 and the primary pattern is not; and 3 when the primary pattern is 4 or 5. The order matters: for example, 3+5 and 5+3 both total 8 but fall into different CAPRA point categories.

=IF(COUNT(B2:B6)<>5,"Enter all five valid component points",IF(OR(MIN(B2:B6)<0,B2>4,AND(B3<>0,B3<>1,B3<>3),B4>1,B5>1,B6>1,B2<>INT(B2),B3<>INT(B3),B4<>INT(B4),B5<>INT(B5),B6<>INT(B6)),"Enter all five valid component points",SUM(B2:B6)))

A reported risk grouping is not a treatment plan

UCSF describes scores 0–2 as low, 3–5 as intermediate and 6–10 as high. The grouping below labels the calculated total according to that description; it does not select surveillance, imaging, surgery, radiation, or another treatment.

The percentage of positive cores uses a 34% boundary in the UCSF table, and age at diagnosis uses 50 years. PSA and tumor stage have their own specific categories. Consult the source and the care team to assign component points; different instruments and clinical contexts should not be mixed.

=IF(ISNUMBER(B8),IF(B8<=2,"Low (0–2)",IF(B8<=5,"Intermediate (3–5)","High (6–10)")),B8)

Interpreting evidence

In the original post-prostatectomy cohort, recurrence-free survival was estimated using that study’s definition of recurrence. A later external validation observed different proportions in its own cohort. Such group estimates cannot decide an individual treatment or directly compare treatments for one person.

Clinical decisions should incorporate the full pathology, stage, health and preferences with an appropriately trained clinician. The spreadsheet provides an educational calculation and does not replace individualized clinical assessment.

Try the example

Use the original values or change them to test your understanding.

Further reading